Fig. 4From: A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigationPipeline of selection of putative UGT2B10 ligands for molecular docking. Drugs and metabolites were selected based on clinical, chemical, and biological criteria. Molecules were excluded from the selection pipeline as in vitro or in vivo evidence showed that the molecule were not undergoing glucuronidationBack to article page